Clinical Trial Update: Multiple Dose ASM8 in Mild Asthmatics [Phase 1, Phase 2]

View source ↗

Summary

The trial update reports the completion of multiple-dose ASM8 studies in adults with mild asthma across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• ASM8

Snippet

Sponsor: Syntara | Conditions: Asthma | Phase 1, Phase 2 | Status: COMPLETED